Latest News & Updates

Breaking News

  • 21 hours ago

  • Pharma Now Editorial Team

FDA Gains Full Approval for Veklury Following EUA-to-Approval Transition in COVID-19 Treatment
Breaking News
FDA Authorizes Gohibic Vilobelimab Injection for Hospitalized COVID-19 Adults on Mechanical Ventilation

Pharma Now Editorial Team

Other trending news you may like to read

FDA Gains Full Approval for Veklury Following EUA-to-Approval Transition in COVID-19 Treatment

FDA's full approval of Veklury sets a precedent for EUA-to-approval transitions, with direct implications for manufacturers in accelerated regulatory frameworks.

Pharma Now Editorial Team

Pharma Now

FDA Authorizes Gohibic Vilobelimab Injection for Hospitalized COVID-19 Adults on Mechanical Ventilation

FDA issues EUA for Gohibic (vilobelimab) IV injection in hospitalized COVID-19 adults on mechanical ventilation, setting sterile injectable and labeling benchmarks.

Pharma Now Editorial Team

Pharma Now

FDA Grants Remdesivir Emergency Use Authorization for Severe COVID-19 in Hospitalized Patients

FDA's 2020 remdesivir EUA offers a durable framework reference for manufacturers structuring regulatory dossiers under emergency authorization pathways.

Pharma Now Editorial Team

Pharma Now

MSP Vaccine Company Gains FDA Approval Update for VAXELIS Hexavalent Combination Vaccine in March 2026

FDA issued a March 2026 approval letter for MSP Vaccine Company's VAXELIS, the hexavalent pediatric combination vaccine licensed under STN 125563.

Pharma Now Editorial Team

Pharma Now